NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 18,000,000 | $312,552,000 | 2.03% |
| DeepCurrents Investment Group LLC | 21,930,000 | $38,044,000 | 1.14% |
| WOLVERINE ASSET MANAGEMENT LLC | 44,563,000 | $77,351,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $20,863,000 | 0.37% |
| Polar Asset Management Partners Inc. | 15,000,000 | $26,056,000 | 0.27% |
| Eisler Capital (UK) Ltd. | 2,500,000 | $4,367,000 | 0.25% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $2,608,000 | 0.23% |
| Verition Fund Management LLC | 7,386,000 | $12,796,000 | 0.12% |
| PFM Health Sciences, LP | 2,000,000 | $3,480,000 | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 21,917,000 | $37,971,000 | 0.09% |